Prenatal Testing Market Size Worth USD 14.82 Billion in 2032 | Emergen Research

The growing awareness of the benefits of advanced testing procedures and the rising incidence of miscarriage is driving the demand for the prenatal testing market.

Vancouver, Nov. 16, 2023 (GLOBE NEWSWIRE) — The global Prenatal Testing Market is forecasted to be worth USD 14.82 Billion by 2032, according to a current analysis by Emergen Research. The rapid growth of the Prenatal Testing Market can be attributed to the growing awareness of the benefits of advanced testing procedures. Alongside this, the increasing incidence of miscarriage is anticipated to further drive the market growth over the forecasted period. Furthermore, the rising government initiatives to encourage prenatal testing as well as several favorable checkup schemes for below poverty communities in developing and underdeveloped nations are also expected to boost the market growth of the prenatal testing market over the forecasted timeframe.

However, in developing and underdeveloped countries, the lack of advanced healthcare services is expected to hinder market development over the forecast timeline.

Receive the FREE Sample Report of Prenatal Testing Market Research Insights @ https://www.emergenresearch.com/request-sample/371

Segments Covered in the report

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/371

MAJOR COMPANIES and Market Share Analysis

The market for Prenatal Testing is consolidated, with a few numbers of medium and small-sized players. Some of the top players in the Prenatal Testing Market comprise:

• Quest Diagnostics
• GeneDx, Inc.
• Natera, Inc.
• Illumina, Inc.
• Ravgen Inc.
• Prenatal Paternities, Inc.
• Ariosa Diagnostics, Inc.
• Eurofins NTD, Inc.
• Counsyl, Inc.
• LabCorp

Strategic Development

In August 2020, Mid America Clinical Laboratories, LLC, was acquired by Quest Diagnostics. With the acquisition, Quest Diagnostics will deliver Professional Laboratory Management for almost 30 hospitals of Community Health Network and Ascension St. Vincent in Indiana. Moreover, AmeriPath, Quest Diagnostics’ specialty in pathology, will continue to offer facilities to these hospitals and, in large part, in Indiana.

In July 2020, Enancio SAS was acquired by Illumina, Inc. In DRAGEN, the scalable cloud data exchange with the Illumina Analytics Platform (IAP) and BlueBee technology, Illumina now features one of the most diverse and specialized dual analytics platforms in the sector and combines this, fosters cost-efficient, easy and convenient workflow for its clients. Illumina now has exceptional data cloud services with Enancio and BlueBee on board.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/371

Key Highlights From The Report

• In September 2020, Grail Inc. acquired by Illumina, Inc. With this acquisition, Illumina will introduce the standardized and widely available blood-based screening, which allows early diagnosis of cancer while treatment can be more accurate and less expensive.
• Over the forecast timeframe, the Trisomy segment is expected to dominate the market with a CAGR of 13.2%. It can primarily be attributed to forces including increased maternal age and a growing number of chromosome abnormalities.
• Due to the propensity for Prenatal Testing for microdeletion and microduplication syndromes in patients, the Micro-deletions Symptoms segment is expected to grow significantly.
• As non-invasive prenatal testing and substantial technological advancements in the field of prenatal testing are being rapidly integrated, the involvement of professionals and a higher reimbursement scenario are happening; the hospital segment is expected to witness considerable growth over the forecast timeframe.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/prenatal-testing-market

Emergen Research has segmented the global Prenatal Testing Market on the basis of method, test-type application, end-use, and region:

• Method Outlook (Revenue, USD Billion; 2019-2032)
  • Blood or Saliva
  • Urine
  • Ultrasound
  • Amniocentesis
  • Chorionic villus sampling
  • Percutaneous umbilical blood sampling
• Test Type Outlook (Revenue, USD Billion; 2019-2032)
  • Invasive
  • Non-Invasive
• Application Outlook (Revenue, USD Billion; 2019-2032)
  • Microdeletions Symptoms
  • Trisomy
  • Others
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
  • Specialty Clinics
  • Hospitals
  • Diagnostic Centers
• Regional Outlook (Revenue, USD Billion; 2019-2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Mammography Workstations Market By Modality (Standalone, Multimodal), By Application (Advance Imaging, Diagnostic Screening, Clinical Review), By End-use (Academia, Hospitals, Breast Care Centers) and By Region, Forecasts to 2027

Next Generation Implants (NGI) Market By Application (Orthopedic Implants, Cardiovascular Implants, Ocular Implants, Dental Implants, Others), By Material (Metals and Metal Alloys, Ceramics, Polymers, Biologics, Others), By End-Use (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Academic and Research Institutes), By Region Forecast to 2028

Near Infrared Imaging Market By Type, By Application (Oncology, Preclinical Imaging, Gastrointestinal Surgeries, Others), By End-use (Hospitals, Molecular Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region Forecast To 2030

Flow Imaging Microscopy Market By Sample Type (Large Biomolecule, Small Biomolecules, Liquid & Viscous Samples, Microfibers and Nano fibers, Others), By Sample Dispersion (Wet Dispersion, Dry Dispersion), By End-Use (Biotechnology Companies, Pharmaceutical Companies, Water Testing Laboratories, Food & Beverage Companies, Research & Academia, Metal Manufacturing, Chemical & Petrochemical Industries), and By Region Forecast to 2028

Drug Infusion Systems Market, By Product (Infusion Pumps, Consumables, and Others), By Application (Chemotherapy, Diabetes Management, and Others), and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Prenatal Testing Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-prenatal-testing-market